To introduce the potential of breath analysis as a diagnostic or monitoring tool in diabetes.
INTRODUCTION
A large portion of diagnostic and monitoring procedures in clinical practice involve blood testing or other complex and costly methodologies (MRI, PET, scanning, etc.). The quest for alternative, noninvasive, practical, and ideally low-cost alternatives is the focus of constant efforts by researchers and manufacturers of medical devices. In this context, tests based on the analysis of exhaled gases represent ideal candidates, due to the ease and flexibility of breath collection. Once collected, exhaled gases can be quantified in a variety of ways, each entailing specific advantages and technical challenges. A concise synopsis of available techniques is provided in Table 1 [1, [5] [6] [7] 29, 32] , whereas more comprehensive evaluations of these methodologies can be found in several recent excellent reviews [1] [2] [3] [4] .
Unfortunately, few clinically approved breathbased tests currently exist. A large number of studies, however, in recent years have demonstrated the potential applicability of this methodology to a variety of clinical conditions. Several of such studies published in the past 12 months are summarized in Table 2 [8-12,13 & ] Diabetes and blood glucose testing Type 1 and type 2 diabetes mellitus (T1DM and T2DM) are an ever-growing problem, with a combined affected population potentially reaching, by some estimates, 450 million in the next 20 years [14] . An increased risk of developing cardiovascular complications is the main cause for long-term morbidity and mortality in diabetic patients. In these patients, a subclinical state of inflammation is constantly present, whether they are aware of it or not; this is now believed to be the main pathogenic mechanism leading to the onset and progression of cardiovascular complications. Dysregulated inflammation (activation of circulating leukocytes and systemic release of cytokines and chemokines) causes systematic, widespread damage to the vascular wall via build-up of atherosclerotic plaques, which gradually reduce and eventually may completely occlude the vascular lumen in virtually all tissues of the body.
The main stimulus causing this exacerbation of inflammation in diabetes is the hallmark of the disease, that is hyperglycemia (excess amounts of glucose in the bloodstream); how high, how often, and how long hyperglycemia is experienced has, in fact, been clearly shown to correlate with the occurrence and severity of diabetic cardiovascular complications [17] . Prevention of hyperglycemic episodes is therefore the very base of diabetes management. The key piece of information required to achieve this goal is the patient's blood glucose level ideally measured at least at several critical time points during the day. Devices able to accurately monitor plasma glucose have therefore become integral parts of the life of diabetic patients.
Why use breath analysis for diabetes?
Currently, glucose meters requiring a finger prick to obtain a sample of the patient's blood are the main methods used to monitor glucose levels. Although
KEY POINTS
Breath analysis is an appealing, painless, and noninvasive alternative to current blood testing methodologies used to diagnose and monitor diabetes, measuring plasma glucose and other related variables.
Technical and analytical difficulties that in the past have slowed the development of the technique have now largely been solved, raising the hope that practically usable testing devices will be developed within a few years.
While no single exhaled compound has proved sufficient to predict plasma glucose or any other related variable, numerous compounds have been shown to be consistently affected by changes in glucose metabolism.
These compounds have various origins, being produced endogenously by peripheral cells or tissues, or being inhaled with ambient air and partly metabolized.
Integrated analysis of the simultaneous profiles of multiple exhaled gases collected during prolonged metabolic fluctuations in healthy, obese, and diabetic patients has allowed the accurate prediction of corresponding plasma variables in controlled experimental conditions. Classic tracer studies Infusion of molecules tagged with either stable/radioactive isotopes followed by isotope quantification in exhaled breath to study b-oxidation and other metabolic pathways [2] Gas chromatography and mass spectroscopy of VOCs Improved to such extent that VOCs are now routinely identified and quantified accurately in the part-per trillion range Sample are preconcentrated by
Sorbent trap absorption
Solid-phase micro extraction Cryofocussation Analysis is then performed by gas chromatography coupled with flame ionization or flame photometric detectors, or by mass selective detectors [1, 9] Direct measurements in EBC of compounds of interest (glucose, lipids)
Exhaled breath trapped in collection tube, cooled to aqueous form, and analyzed by various chromatographic techniques [3, 4] Frequent gas sampling or real-time analysis Atmospheric pressure ionization mass spectrometry þ electrospray charging (used for on-line measurements of volatilized fatty acids [6] Proton transfer reaction mass spectrometry (PTR-MS) for measurement of breath VOCs
Used for on-line measurements of volatilized fatty acids [5] and proton transfer reaction mass spectrometry for measurement of breath VOC EBC, exhaled breath condensate; VOCs, volatile organic compounds.
this methodology is relatively efficient, it is rather expensive (a new test-strip must be used each time, costing about 1 US dollar), and the constant need of piercing the skin to reach the capillary bed required an average of three to five times daily by most patients is bothersome, painful, and may cause skin hardening and difficulty in obtaining good samples. In many cases, this results in poor patient compliance [15] . These concepts are well exemplified in the word of a patient who wrote to our laboratory upon learning that we were trying to develop alternative, noninvasive, and painless techniques to measure blood sugar:
'. . .. the pain of taking blood from my fingers has made it to where I just don't do it hardly anymore. . .'
This deterrence of patients from monitoring their blood glucose levels, therefore, almost inevitably results in worse glycemic control and higher likelihood of developing serious cardiovascular complications.
Any methodology allowing blood glucose measurement in a painless, noninvasive way is therefore likely to be very well received by diabetic patients, and will significantly improve compliance and glycemic control. Among several possible techniques being developed for this purpose, the use of exhaled volatile organic compounds (VOCs) appears especially promising. The noninvasive nature of this method and flexibility of its application may provide a number of key advantages. In addition to the obvious possible improvements in diabetic patients' management of the disease and quality of life (reduced pain and calluses from constant finger pricking), the application of breath analysis can be useful in a series of additional settings, such as real-time glucose monitoring during surgical procedures or other situations when patients are unconscious (samples can be collected from patients without their collaboration) [16] . Further, the use of breath analysis can be beneficial in large-scale screening programs, where obtaining blood samples may be limited by a number of factors, such as difficult vein access, young age of screened populations, or simple refusal to undergo a needle stick.
Despite these many possible advantages, and considerable interest in the field, a clinically applicable breath-based glucose test has not yet been fully developed. With improved abilities to measure breath compounds present at extremely low concentrations with increasing accuracy, the creation and use of such a breath testing system, however, appears now to rapidly approach reality. Pulmonary nodules Gas chromatography, mass spectrometry, solidphase micro extraction, and chemical nano-array used to analyze VOCs in patient's breath Breath analysis able to distinguish between benign and malignant pulmonary nodules [15] VOCs, volatile organic compounds.
EXHALED COMPOUNDS IN HEALTHY AND DYSMETABOLIC CONDITIONS
The composition of human breath is complex. Exhaled gas concentrations may be the result of several diverse processes, such as re-exhalation of gases inhaled from ambient air (which may be inert, or partly metabolized endogenously); exhalation of gases produced by the lungs, or produced in peripheral tissues and transported to the lungs through the bloodstream; and any combination of the above. A synopsis of these mechanisms is provided in Table 3 [17 -27] .
Functional aspects of exhaled gases
Whereas at least some gases may be present in exhaled mixtures as mere 'bystanders', that is with no apparent biological function (and these may either be inhaled from ambient air, or be the by-product of endogenous biochemical reactions), others may exert a range of effects of cells and tissues. Some of these mechanisms are listed in Table 4 [28] [29] [30] [31] [32] [33] [34] [35] [36] .
Issues associated with breath-based testing in diabetes
Whereas the noninvasive component of breath analysis is attractive to people with diabetes, some intrinsic features of the condition may complicate the accuracy of breath-based testing. The effects of diabetes are far-reaching into the body, and any alteration in physiological processes that may affect exhaled breath composition (and thereby affect the accuracy of breath testing) should be identified and taken into account for proper adjustments. Lung function can be directly or indirectly affected by diabetes. It has been shown that T1DM and T2DM patients are likely to develop restrictive lung disease and that the occurrence of Table 3 . Origin of gases found in human breath mixture
Atmospheric air
VOCs present in ambient air are inhaled and then exhaled at varying concentrations; if inert, inhaled and exhaled concentrations are equal [17] If VOCs are also produced endogenously, exhaled concentrations will exceed inhaled concentrations Some VOCs undergo partial or total enzymatic metabolisms, resulting in lower exhaled than inhaled concentrations. In this situation, acute metabolic changes can modify the inhaled/exhaled ratio, linking exhaled levels to specific metabolic events (i.e. hyperglycemia suppressing enzymatic catabolism of ethylbenzene and xylenes, reducing the net uptake of these gases) [20] Lungs The internal surfaces of the lungs may directly contribute to exhaled mixture of gases Pulmonary surface liquid can become aerosolized into the breath, resulting in measurable concentrations of arachidonic acid metabolites (eicosanoids), isoprostanes, leukotrienes, proteins, and cytokines in exhaled breath condensate [21] Unique combinations of VOCs are generated specifically in diseased states (i.e. the interaction of 22 VOCs in lung cancer), suggesting the direct transmission of these VOCs from the lungs to exhaled breath Peripheral tissues Peripheral human cells and tissues contribute to exhaled VOC through their release into the bloodstream and subsequent transfer into the airways (i.e. ethane, isoprene, pentane, and other hydrocarbons are proposed biomarkers for metabolic processes such as fat oxidation, cholesterol/ LDL concentrations and oxidative stress levels)
The exact mechanisms of transferring systemically produced VOCs from tissues into the lungs are still unclear Blood Blood components themselves can produce VOCs Acetone, dimethyl sulfide, isoflurane, isoprene, pentane, and may more gases are commonly found in whole blood; as many as 74 compounds have been simultaneously identified in blood and exhaled breath [22 && ] Polymorphonuclear leukocytes (PMNs) have been shown to produce acetaldehyde, hexanaldehyde, and other gases [23, 24] ; as these cells are often found sequestered in the lungs at high concentrations in disease states, VOC transfer into exhaled breath is possible [25] ; altered VOC production by PMNs may be present in dysmetabolic states, including diabetes, becoming a potential marker of onset/progression of disease [26, 27] Microorganisms If identified with exhaled gas mixtures, unique gas profiles of bacteria and other microorganisms can be used for diagnostic or monitoring purposes (i.e. radiolabeled urea detects Helicobacter pylori, a urease-positive bacterium; hydrogen cyanide detects Pseudomonas aeruginosa [28] ; a group of VOCs were found to be secreted in vitro by Mycobacterium tuberculosis) [29] VOCs, volatile organic compounds.
glycation in diabetic patients can decrease the lung's ability to efficiently transfer or diffuse gases [37] . Receptors for advanced glycation end-products (RAGE) display greater ligand binding in diabetic patients as opposed to healthy individuals. This increased binding has proinflammatory effects, increases prosclerotic and profibrotic growth factors, and decreases bioavailability of nitric oxide leading to dysfunction in pulmonary arteries [22 && ]. In addition, high levels of myeloperoxidase (MPO) and a-defensins, derived from circulating polymorphonuclear leukocytes (PMNs), have been reported in diabetic patients [12,22 && ]. MPO exerts strong oxidative effects, and its excessive levels have been associated with chronic arterial disease; adefensins also facilitate the development of atherosclerosis, and disrupt the barrier between capillaries and epithelial tissue in the lungs, thereby increasing the chances of lung injury [38, 39] .
In diabetic patients, several key endogenous metabolic processes may also be altered in a way that induces changes in exhaled gas profiles. For instance, during hyperglycemia, specific VOCs may increase in breath due to direct fermentation (or other chemical degradation) of glucose [18] . Other changes in exhaled gas profiles may be induced by hyperglycemia indirectly, such as a drop in exhaled ketones due to the antilipolytic effect of insulin, which increases in response to rising blood sugar [42] . Another factor affecting breath composition is diet, which has been shown to differ considerably across groups of patients. T1DM patients, for instance, tend to reduce carbohydrate intake, in favor of a balanced mix of nutrients rich in both protein and lipid, whereas the proportion of lipids appears much greater in T2DM. Fat ingestion is associated with greater exhaled levels of methyl nitrate and other ketones, as well as other gases [40] .
Altered gas profiles in diabetes
The initial approach to the use of breath analysis in the field of diabetes has traditionally been the identification of individual exhaled compounds whose concentration was either altered by the presence of diabetes per se, or associated with specific metabolic aspects or comorbidities of diabetes. Glucose itself, for instance, in aerosolized form, was found to be increased in exhaled breath condensates (EBCs) during induced hyperglycemia [41] . Exhaled levels, however, correlated rather poorly with the magnitude of hyperglycemia. Acetone, on the contrary, has been by far the compound receiving the greatest attention. Massively elevated acetone exhalation is typical of diabetic ketoacidosis, and smaller increases have been reported in diabetic populations; in fact, a linear relationship between average breath acetone levels and blood glucose concentration was reported in T1DM [42, 43] , but not in T2DM patients [44, 45] . Measurement of acetone alone, however, has proven insufficient to estimate blood glucose levels, due to considerable variability across patients, even in the presence of similar glucose levels.
A number of other exhaled compounds are linked with various aspects of diabetes. Methyl nitrate, for instance, was highly correlated with the magnitude of hyperglycemia in a cohort of NO ! vasodilation of endothelial cells, neuronal synaptic plasticity, and antibacterial defense [30] Ethylene ! increases regulation of defensins and antagonize glucose homeostasis in Arabidopsis plants CO ! platelet aggregation and inhibition of smooth muscle proliferation [30] Hydrogen sulfide ! affect Katp channels and vasodilation [5] Exogenous origin Known molecular mechanisms Known effect but unclear molecular mechanisms Trichloroethylene ! up-regulate PPARa [31] Ethyl nitrate ! vasodilatory activity and suppressed methemoglobin formation [33] D-limonene ! antitumorigenic activity [32] Methyl iodide ! increase serum cholesterol and decrease triglycerides [34, 35] Carbon-dioxide ! regulates respiratory function; regulates gene expression, attenuate pro-inflammatory gene expression and enhance anti-inflammatory IL-10 production [6] Dichloromethane, ethylbenzene, and trichloroethylene ! shown to make 1217 identifiable changes in rate gene expression with unidentifiable metabolically active exogenous VOCs [36] CO, Carbon monoxide; IL, interleukin;PPAR a, peroxisome proliferator activated receptor alpha; NO, Nitric oxide; VOCs, volatile organic compounds.
T1DM children [46] . Isoprene was reported to reflect the degree of ongoing cholesterol synthesis [47] . Carbon monoxide, propane, ethane, and pentane appear to reflect the systemic level of oxidative stress. Propionic and butanoic acid levels are greater in EBCs after the ingestion of sucrose [48] . Aromatic compounds like ethylbenzene and toluene are actively metabolized by the liver, in a fashion dependent on hepatic glucose load [18] . Carbon dioxide is a direct oxidative by-product of energy substrates, including glucose. Finally, ethanol and methanol appear to derive from enteric bacterial fermentation of circulating glucose [49, 50] . Whereas all of the above studies revealed interesting correlations, none allowed the accurate prediction through the measurement of a specific exhaled gas of any diabetes-related variable, and in particular of plasma glucose. It is therefore apparent that if any such predictions were to be obtained, they would rather entail the mathematical integration of the simultaneous profiles of multiple gases, ideally measured during broad fluctuations of the variable of interest. Several studies have indeed been performed attempting to estimate plasma glucose via multilinear regression analysis of exhaled gas profiles obtained during an oral glucose tolerance test (10 healthy adults, model including exhaled acetone and ethanol) [49] ; an i.v. glucose tolerance test (10 healthy individuals, model including ethanol, acetone, methyl nitrate, and ethylbenzene) [18] ; and during a 4-h hyperglycemic clamp study (16 healthy and 13 T1DM adults, same 4-VOC model) [51] . In these studies, a high level of concordance was reported between measured and breath-determined plasma glucose levels (in the latter two studies, the mean correlation coefficients were 0.91 and 0.86, respectively). In addition to plasma glucose, parallel studies with similar experimental design also allowed us to estimate with considerable accuracy the plasma levels of insulin [42, 52] , free fatty acids (FFAs), and triglycerides [53,54 & ] both in healthy, obese, and T2DM patients.
CONCLUSION
As the need for alternate modalities of diabetes management grows, large resources have been invested worldwide in developing noninvasive devices. Of these, breath analysis methods appear to be on the verge of major breakthroughs that can hopefully accelerate the transition of past theoretical concepts into practical clinical devices that will allow diagnosis and, more importantly, daily management of diabetes. A number of analytical challenges that impeded accurate measurement of very low gas concentrations have been now virtually eliminated, and several controlled, complex studies in children and adults with and without diabetes have demonstrated the feasibility of accurate breath-based tests for not only glucose, but other relevant variables such as insulin, FFAs, and triglycerides. The transition towards development of actual prototypes of testing devices that can be used on large-scale clinical trials, however, still awaits the resolution of a number of issues. It appears, for example, that the whole range of possible glycemic levels relevant to diabetes, especially concerning hypoglycemia (whose accurate detection is crucial in type 1 diabetes) has not yet been thoroughly explored. Further, current studies reporting breath-based predictions of blood glucose have not yet documented the stability of their measurements over time, or the reproducibility of data obtained in highly controlled experimental conditions translated to real-life settings. Additional confounding variables that need to be addressed also include the effects of prior food ingestion, exposure to different air mixtures, prior glycemic control, duration of diabetes, and concomitant presence of tissue complications. The logical next steps in the field therefore appear to address these complex issues, while developing viable partnerships between clinical researchers and private sector entities, leading to the development, testing, and marketing of testing devices. Finally, it should be noted that, for the purposes of this review, exhaled gas profiles have so far been considered as simple 'mathematical components' of predictive equations leading to the estimations of metabolic variables relevant to diabetes. Considerable intrinsic value, however, is definitely also retained by the study of the biochemical significance of the changes in exhaled gases per se, especially for gases present at very low concentrations or previously not associated with altered metabolism. These findings can lead to novel insights into the complex field of energy substrate metabolism.
